Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Role of Biologics in Psoriasis
Biologics have revolutionized the treatment of psoriasis, offering targeted therapies that specifically address the underlying mechanisms of the disease. Unlike traditional systemic treatments, which can have broad immunosuppressive effects, biologics target specific components of the immune system involved in psoriasis pathogenesis. This precision has led to significant improvements in efficacy and safety for patients with moderate to severe psoriasis. The most commonly used biologics in psoriasis treatment include TNF inhibitors, IL-12/23 inhibitors, IL-17 inhibitors, and IL-23 inhibitors. These biologics have demonstrated remarkable success in reducing psoriatic lesions, improving skin clearance, and enhancing the quality of life for patients. Clinical trials and real-world studies have shown that biologics can achieve rapid and sustained remission in many patients, with some experiencing near-complete resolution of their symptoms.
Therefore, get an overall knowledge of updated Role of Biologics in Psoriasis
See More Webinars @ Hidoc Webinars
1.
Study opens up possibility of bespoke prostate cancer treatment
2.
Why Encouragement May Not Improve Motivation in Depression
3.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
4.
A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.
5.
Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.
1.
Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer
2.
Patient Management for Bone Marrow Functional Recovery Pathways
3.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
4.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
5.
Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
Early Cancer Detection Saves Lives
5.
How Platelet Disorders Can Affect the Body
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation